CD22 and neoplasm: We noted that CD22 and CD138 expression was not changed by MFI measurement (Fig 5C), suggesting that while some cells downregulated expression of these markers during tumor development it was on a per cell basis, and not a phenomenon that globally applied to the entire cell population.